Furthermore, ATR inhibition downregulates PD-L1 expression in tumor cells by destabilizing PD-L1 in a proteasome-dependent manner and has resulted in enhanced immune cell killing (Sun et al., 2018). The gene discussed is CD274; the disease is neoplasm.